Oscar Health Inc is trading 6.9% up at $26.20 as buyers extend this week’s rally following a recent analyst upgrade.
- The move is primarily driven by follow-through momentum from a June 4 upgrade and price-target hike by Wells Fargo, which continues to act as a significant catalyst.
- Broader market strength is providing additional support for the advance, with the Nasdaq trading higher and growth stocks leading the session.